6
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model

Pages 105-116 | Published online: 10 Jul 2009

References

  • Anderson JR, Field HJ (1983). The distribution of herpes simplex type 1 antigen in mouse central nervous system after different routes of inoculation. JNeurol Sci 60: 181–195.
  • Bergstrom T, Vahlne A, Alestig K, Jeansson S, Forsgrenm, Lycke E (1990). Primary and recurrent herpes simplex virus type 2-induced meningitis. I Infect Dis 162: 322–330.
  • Corey L, Spear PG (1986). Infections with herpes simplex viruses. N Engl J. Med 314: 686–691.
  • Craig CP, Nahmias AJ (1973). Different patterns of neuro-logic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis 127: 365–372.
  • Day SP, Lausch RN, Oakes JE (1988). Evidence that the gene for herpes simplex virus type 1 DNA polymerase ac-counts for the capacity of an intertypic recombinant to spread from eye to central nervous system. Virology 163: 166–173.
  • Galloway DA, Swain M (1980). Cloning of herpes simplex virus type 2 DNA fragments in a plasmid vector. Gene 11: 253–257.
  • Georgsson G, Martin JR, Stoner GL, Webster HF (1987). Virus spread and initial pathological changes in the ner-vous system in genital herpes simplex virus type 2 infec-tion in mice. A correlative immunohistochemical, light and electron microscopic study. Acta Neuropathol 72: 377–388.
  • Gressens P, Langston C, Martin JR (1994). In situ PCR local-ization of herpes simplex virus DNA sequences in dis-seminated neonatal herpes encephalitis. I Neuropathol Exper Neurol 53: 469–482.
  • Gressens P, Martin JR (1994). In situ polymerase chain reaction-Localization of HSV-2 DNA sequences in in-fections of the nervous system. I Virol Methods 46: 61–83.
  • Hill TJ, Field HJ, Blyth WA (1975). Acute and recurrent in-fection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. I Gen Virol 28: 341–353.
  • Kern ER, Richards JT, Glasgow LA, Overall JC Jr, de, Miranda P. (1982). Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir. Am J Med 73: 125–131.
  • Kesari S, Lasner TM, Balsara KR, Randazzo BP, Lee VM, Trojanowski JQ, Fraser NW (1998). A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous sys-tem. J. Gen Virol 79: 525–536.
  • Kesari S, Lee VM, Brown SM, Trojanowski JQ, Fraser NW (1996). Selective vulnerability of mouse CNS neurons to latent infection with a neuroattenuated herpes simplex virus-1. JNeurosci 16: 5644–5653.
  • Levitz RE (1998) Herpes simplex encephalitis: a review. Heart Lung 27: 209–212.
  • Lewandowski G, Hobbs MV (1998). Evidence for defici-encies in intracerebral cytokine production, adhesion molecule induction, and T cell recruitment in her-pes simplex virus type-2 infected mice. I Neuroim-munol 81: 58–65.
  • Lewandowski G, Hobbs MV, Bloom FE (1994). Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol 55: 23–34.
  • Lewandowski G, Hobbs M, Geller A (1998). Evidence that deficient IFN-gamma production is a biological basis of herpes simplex virus type-2 neurovirulence. J Neuroim-m unol 81: 66–75.
  • Lewandowski GA, Lo D, Bloom FE (1993). Interfer-ence with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. Proc Nail Acad Sci USA 90: 2005–2009.
  • Martin JR, Stoner GL, Webster HD (1982). Lethal encephali-tis and non-lethal multifoc al central nervous system de-myelination in herpes simplex virus type 2 infections in mice. Br J Exper Pathol 63: 651–666.
  • Meyding-Lamade U, Haas J, Lamade W, Stingele K, Kehm R, Fath A, Heinrich K, Hagenlocher BS, Wildemann B (1998a). Herpes simplex virus encephalitis-long term comparative study of viral load and the expression of immunologic nitric oxide synthase in mouse brain tis-sue. Neurosci Lett 244: 9–12.
  • Meyding-Lamade U, Lamade W, Kehm R, Knopf KW, Hess T, Gosztonyi G, Degen O, Hacke W (1998b). Herpes simplex virus encephalitis-cranial magnetic resonance imaging and neuropathology in a mouse model. Neu-rosci Lett 248: 13–16.
  • Meyding-Lamade U, Lamade W, Kehm R, Oberlinner C, Fath A, Wildemann B, Haas J, Hacke W (1999). Herpes simplex virus encephalitis: chronic progressive cerebral MRI changes despite good clinical recovery and low viral load-an experimental mouse study. Eur I Neurol 6: 531–538.
  • Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr (1982). Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 145: 829–836.
  • Oakes JE, Gray WL, Lausch RN (1986). Herpes simplex virus type 1 DNA sequences which direct spread of virus from cornea to central nervous system. Virology 150: 513–517.
  • Post MJ, Tate LG, Quencer RM, Hensley GT, Berger JR, Sheremata WA, Maul G (1988). CT, MR, and pathology in HIV encephalitis and meningitis. AIR Am I Roentgenol 151: 373–380.
  • Sarkar SK, Kapadia RD (1992). Magnetic resonance imag-ing in drug discovery research. In: Magnetic resonance microscopy. Blumish B, Kuhn W (eds). Weinheim: VCH, pp 513–531.
  • Skoldenberg B (1996). Herpes simplex encephalitis. Scand J Infect Dis Suppl 100, 8–13.
  • Sucato G, Wald A, Wakabayashi E, Vieira J, Corey L (1998). Evidence of latency and reactivation of both herpes sim-plex virus (HSV)-1 and HSV-2 in the genital region. I Infect Dis 177: 1069–1072.
  • Thompson RL, Stevens JG (1983). Biological characteriza-tion of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology 131: 171–179.
  • Tucker T, Dix RD, Katzen C, Davis RL, Schmidley JW (1985). Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann Neurol 18: 74–79.
  • Vahlne A, Svennerholm B, Sandberg M, Hamberger A, Lycke E (1980). Differences in attachment between her-pes simplex type 1 and type 2 viruses to neurons and glial cells. Infect Immun 28: 675–680.
  • Whitley RJ, Kimberlin DW, Roizman B (1998). Herpes sim-plex viruses. Clin Infect Dis 26: 541–553.
  • Whitley RJ, Lakeman F (1995). Herpes simplex virus in-fections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 20: 414–420.
  • Xu S, Jordan EK, Li W, Yang Y, Chesnick SA, Webster HD, Brocke S, Quigley L, McFarland HF, Frank JA (1998). in vivo three-dimensional MR microscopy of mice with chronic relapsing experimental autoimmune encephalomyelitis after treatment with insulin- like growth factor-I. AJNR Am J Neuroradiol 19: 653–658.
  • Yeung KC, Oakes JE, Lausch RN (1991). Differences in the capacity of two herpes simplex virus isolates to spread from eye to brain map to 1610 base pairs of DNA found in the gene for DNA polymerase. Curr Eye Res 10 Suppl: 31–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.